Researchers visualize alpha-synuclein pathology in living patients with a neurodegenerative disorder
Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by the aggregation of α-synuclein in the brain. Now, scientists from Japan, in collaboration with three pharmaceutical companies, have developed a radioligand that…